Do we need alternative treatment options for autoimmune hepatitis?
Csepregi
Antal
A
Department of Gastroenterology, Hepatology, and Infectious Diseases, Otto-von-Guericke University, Magdeburg, Leipziger Strasse 44, D-39120, Magdeburg, Germany.
Malfertheiner
Peter
P
D005938:Glucocorticoids / Q000627:therapeutic use*; D019693:Hepatitis, Autoimmune / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016896:Treatment Outcome
D005938:Glucocorticoids; D007166:Immunosuppressive Agents